SCHEMBL19078936

SCHEMBL19078936

Cc1ccc(-c2cc(-c3ccc(C(=O)N4CCC(F)(F)CC4)cc3)cc3cc(CN)sc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK4 O96013 2/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ LIPC P11150 2/20 0.40
▸ GABRD O14764 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ GABRA4 P48169 1/20 0.38
▸ KDM1A O60341 4/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ ABL1 P00519 2/20 0.37
▸ BCR P11274 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SLC6A7 Q99884 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18541435 0.92 PAK4 (0.48) PAK4NAMPTPAK1LIPCABL1
SCHEMBL17844696 0.85 LIPC (0.40) PAK4NAMPTPAK1LIPCMAPT
SCHEMBL19753621 0.84 PAK4 (0.47) PAK4NAMPTPAK1LIPCMEN1
SCHEMBL18325906 0.81 PAK4 (0.55) PAK4NAMPTPAK1LIPCGABRD
SCHEMBL19742290 0.81 PAK4 (0.49) PAK4NAMPTPAK1LIPCMEN1
SCHEMBL19078937 0.79 NAMPT (0.45) PAK4NAMPTPAK1
SCHEMBL19753619 0.77 P2RY12 (0.40) PAK4NAMPTPAK1LIPCKMT2A
SCHEMBL18325911 0.77 PAK4 (0.54) PAK4NAMPTPAK1GABRDGABRA1
SCHEMBL17859366 0.77 PAK4 (0.46) PAK4NAMPTPAK1LIPCFASN
SCHEMBL19753597 0.76 GABRA5 (0.44) PAK4LIPCGABRA5MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017117447-A1 MULTICYCLIC COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. (US) 2017-07-06 — — WO disclosed
Send feedback